source
- MacroGenics sells manufacturing arm; West Pharma discloses cybersecurity attackPlus, news about Bavarian Nordic and OrganaBio’s new CDMO subsidiary: 🏭 Bora buys MacroGenics' manufacturing operations: MacroGenics is selling its clinical and commercial drug substance productio…Endpoints · 2mo ago↗ source
- Clinical Implementation and Surveillance Strategiesonclive · 2mo ago↗ source
- With new data, Regenxbio to seek FDA approval of Duchenne gene therapyThough two serious side effects muddied the results, CEO Curran Simpson expressed optimism about a clearance and claimed FDA leadership will have a “mandate on rare disease flexibility.”BioPharma Dive · 2mo ago↗ source